Dani Rabinowitz advises on the application of EU and UK competition law across a wide range of industry sectors, including pharmaceuticals, healthcare, insurance and technology. Dani also has experience advising on foreign investment, procurement and subsidy control.
Prior to joining Clifford Chance, Dani was a research fellow in the Faculty of Philosophy at the University of Oxford.
- Advising a private equity client on the merger control aspects of its acquisition of a listed pharmaceutical company.
- Advising a private equity client on the merger control and foreign investment aspects of its acquisition of a composite insurance business.
- Advising a private equity client in relation to allegations of anticompetitive conduct by a former subsidiary.
- Advising a pharmaceutical company on the merger control aspects of its acquisition of certain marketed orphan and pipeline pharmaceutical products.
- Advising a bank on the implications of the National Security and Investment Act for deal-contingent forex swaps.
- Advising a private equity client on the merger control aspects of its acquisition of an education software platform.
- Advising an entrepreneurial development bank on the application of EU procurement law.
- Advising a private equity client on the merger control aspects of its acquisition of a sports nutrition company.
- Advising a financial industry body on its competition protocol
- Advising a packaging company on the acquisition of a competitor.
- Advising a private equity client on the merger control and foreign investment aspects of its acquisition of a software company.
- Advising Louis Dreyfus Company Holdings B.V. on the sale of an indirect 45% equity stake in Louis Dreyfus Company B.V. (LDC) to Abu Dhabi-based ADQ.
News and client work
Contact details
- Clifford Chance, London
- +44 207006 2686
- Email me
- Follow me on LinkedIn
- Practice area Antitrust, EU & trade, M&A corporate
Career and qualifications
- University of Oxford (BPhil) 2008